Late complications after radiotherapy for prostate cancer.

Standard

Late complications after radiotherapy for prostate cancer. / Jung, Horst; Beck-Bornholdt, Hans-Peter; Svoboda, V; Alberti, Winfried; Herrmann, T.

In: STRAHLENTHER ONKOL, Vol. 188, No. 11, 11, 2012, p. 965-974.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Jung, H, Beck-Bornholdt, H-P, Svoboda, V, Alberti, W & Herrmann, T 2012, 'Late complications after radiotherapy for prostate cancer.', STRAHLENTHER ONKOL, vol. 188, no. 11, 11, pp. 965-974. <http://www.ncbi.nlm.nih.gov/pubmed/23053139?dopt=Citation>

APA

Jung, H., Beck-Bornholdt, H-P., Svoboda, V., Alberti, W., & Herrmann, T. (2012). Late complications after radiotherapy for prostate cancer. STRAHLENTHER ONKOL, 188(11), 965-974. [11]. http://www.ncbi.nlm.nih.gov/pubmed/23053139?dopt=Citation

Vancouver

Jung H, Beck-Bornholdt H-P, Svoboda V, Alberti W, Herrmann T. Late complications after radiotherapy for prostate cancer. STRAHLENTHER ONKOL. 2012;188(11):965-974. 11.

Bibtex

@article{0d0f49be1ee14a328bca6ba03df8b3d9,
title = "Late complications after radiotherapy for prostate cancer.",
abstract = "The aim of the present study was to analyze in detail the time course of the incidence of radiation-induced late effects. For this purpose, unpublished data of patients treated by radiation therapy in Hamburg in the late 1980s were analyzed. Relatively large volumes were exposed to comparatively high doses, thus leading to a high rate of treatment-related side effects.",
keywords = "Adult, Germany, Humans, Male, Aged, Middle Aged, Aged, 80 and over, Risk Factors, Cross-Sectional Studies, Combined Modality Therapy, Incidence, Radiotherapy Dosage, Neoplasm Staging, Radiotherapy, Adjuvant, Prostatectomy, Androgen Antagonists/therapeutic use, Orchiectomy, Prostatic Neoplasms/pathology/*radiotherapy/surgery, Radiation Injuries/classification/diagnosis/epidemiology/*etiology, Adult, Germany, Humans, Male, Aged, Middle Aged, Aged, 80 and over, Risk Factors, Cross-Sectional Studies, Combined Modality Therapy, Incidence, Radiotherapy Dosage, Neoplasm Staging, Radiotherapy, Adjuvant, Prostatectomy, Androgen Antagonists/therapeutic use, Orchiectomy, Prostatic Neoplasms/pathology/*radiotherapy/surgery, Radiation Injuries/classification/diagnosis/epidemiology/*etiology",
author = "Horst Jung and Hans-Peter Beck-Bornholdt and V Svoboda and Winfried Alberti and T Herrmann",
year = "2012",
language = "English",
volume = "188",
pages = "965--974",
journal = "STRAHLENTHER ONKOL",
issn = "0179-7158",
publisher = "Urban und Vogel",
number = "11",

}

RIS

TY - JOUR

T1 - Late complications after radiotherapy for prostate cancer.

AU - Jung, Horst

AU - Beck-Bornholdt, Hans-Peter

AU - Svoboda, V

AU - Alberti, Winfried

AU - Herrmann, T

PY - 2012

Y1 - 2012

N2 - The aim of the present study was to analyze in detail the time course of the incidence of radiation-induced late effects. For this purpose, unpublished data of patients treated by radiation therapy in Hamburg in the late 1980s were analyzed. Relatively large volumes were exposed to comparatively high doses, thus leading to a high rate of treatment-related side effects.

AB - The aim of the present study was to analyze in detail the time course of the incidence of radiation-induced late effects. For this purpose, unpublished data of patients treated by radiation therapy in Hamburg in the late 1980s were analyzed. Relatively large volumes were exposed to comparatively high doses, thus leading to a high rate of treatment-related side effects.

KW - Adult

KW - Germany

KW - Humans

KW - Male

KW - Aged

KW - Middle Aged

KW - Aged, 80 and over

KW - Risk Factors

KW - Cross-Sectional Studies

KW - Combined Modality Therapy

KW - Incidence

KW - Radiotherapy Dosage

KW - Neoplasm Staging

KW - Radiotherapy, Adjuvant

KW - Prostatectomy

KW - Androgen Antagonists/therapeutic use

KW - Orchiectomy

KW - Prostatic Neoplasms/pathology/radiotherapy/surgery

KW - Radiation Injuries/classification/diagnosis/epidemiology/etiology

KW - Adult

KW - Germany

KW - Humans

KW - Male

KW - Aged

KW - Middle Aged

KW - Aged, 80 and over

KW - Risk Factors

KW - Cross-Sectional Studies

KW - Combined Modality Therapy

KW - Incidence

KW - Radiotherapy Dosage

KW - Neoplasm Staging

KW - Radiotherapy, Adjuvant

KW - Prostatectomy

KW - Androgen Antagonists/therapeutic use

KW - Orchiectomy

KW - Prostatic Neoplasms/pathology/radiotherapy/surgery

KW - Radiation Injuries/classification/diagnosis/epidemiology/etiology

M3 - SCORING: Journal article

VL - 188

SP - 965

EP - 974

JO - STRAHLENTHER ONKOL

JF - STRAHLENTHER ONKOL

SN - 0179-7158

IS - 11

M1 - 11

ER -